Trial intelligence / Profile preview

The Effect of Naltrexone on Amphetamine Cue Reactivity: An fMRI Study

2010-021384-33Phase 2Completed

Sponsor
Beroendecentrum Stockholm
Start
Jun 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of naltrexone in amphetamine dependence (2 arms), sponsored by Beroendecentrum Stockholm. Primary endpoints: Primary: fMRI BOLD signal in brain reward system and Primary: Functional connectivity on fMRI. Started Jun 2010; status: completed.

02

Drugs

naltrexone
03

Conditions

amphetamine dependence

Beyond the preview

Go deeper on 2010-021384-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-021384-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call